[Analysis of steroids. Part 45: Analytical investigation of pipecuronium bromide (Arduan)]. 1992

M Gazdag, and G Szepesi, and K Mihályfi, and B P Kemenesné, and P Horváth, and Z Végh, and M Rényei, and F Trischler, and S Görög
Richter Gedon Vegyészeti Gyár Rt., Budapest.

The following methods are described for the analytical investigation of pipecuronium bromide. 1. HPLC method. Of the several systems tried for the separation and quantification of impurities and degradation products the best results were obtained using silica as the stationary phase and 43:43:14 mixture of methanol, acetonitrile and concentrated aqueous ammonia containing 0.1 mole/l each of ammonium chloride and ammonium carbonate as the eluent. The validation of this method is presented. The above described aggressive eluent can be successfully replaced by an ion-pairing system using silica as the stationary phase and 96:4 mixture of acetonitrile and water containing 0.1 mole/l sodium perchlorate as the eluent. 2. Thin-layer chromatography. TLC systems are described for the separation and densitometric quantification of the impurities and degradation products of pipecuronium bromide. 3. Spectrophotometry. Two methods are described. The ester groups of the molecule can be determined by the iron(III)-hydroxamate method while for the ion-pair extraction of the quaternary ammonium steroid picric acid or bromthymol blue are used as the reagents. 4. Titrimetry. In addition to the titration with acetous perchloric acid for the assay of the bulk material a microtitration method is described for the determination of pipecuronium bromide in individual lyophylized ampoules (potentiometric titration with 0.1 M silver nitrate).

UI MeSH Term Description Entries
D009466 Neuromuscular Blocking Agents Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (NEUROMUSCULAR NONDEPOLARIZING AGENTS) or noncompetitive, depolarizing agents (NEUROMUSCULAR DEPOLARIZING AGENTS). Both prevent acetylcholine from triggering the muscle contraction and they are used as anesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. Neuromuscular Blocker,Neuromuscular Blocking Agent,Neuromuscular Blockers,Agent, Neuromuscular Blocking,Agents, Neuromuscular Blocking,Blocker, Neuromuscular,Blockers, Neuromuscular,Blocking Agent, Neuromuscular,Blocking Agents, Neuromuscular
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D013053 Spectrophotometry The art or process of comparing photometrically the relative intensities of the light in different parts of the spectrum.
D015113 Androstane-3,17-diol The unspecified form of the steroid, normally a major metabolite of TESTOSTERONE with androgenic activity. It has been implicated as a regulator of gonadotropin secretion. 5 Androstane 3,17 diol,5 alpha-Androstane-3 alpha,17 beta-diol,5 alpha-Androstane-3 beta,17 alpha-diol,5 alpha-Androstane-3 beta,17 beta-diol,5 alpha-Androstane-3alpha,17 beta-diol,5 beta-Androstane-3 alpha,17 beta-diol,5-Androstane-3,17-diol,5alpha-Androstane-3beta,17alpha-diol,5 alpha Androstane 3 alpha,17 beta diol,5 alpha Androstane 3 beta,17 alpha diol,5 alpha Androstane 3 beta,17 beta diol,5 alpha Androstane 3alpha,17 beta diol,5 beta Androstane 3 alpha,17 beta diol,5alpha Androstane 3beta,17alpha diol,Androstane 3,17 diol
D017300 Pipecuronium A piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent (NEUROMUSCULAR NONDEPOLARIZING AGENTS). It is used as a muscle relaxant during ANESTHESIA and surgical procedures. Pipecurium,Arduan,Pipecurium Bromide,Pipecuronium Bromide,Pipecuronium Dibromide, (16 alpha)-Isomer,Pipecuronium Dibromide, (17 alpha)-Isomer,Pipecuronium Dibromide, (3 beta)-Isomer,Pipecuronium Dibromide, Dihydrate,Pipecuronium, Dibromide,RGH-1106,Bromide, Pipecurium,Bromide, Pipecuronium,Dibromide Pipecuronium,Dibromide, Dihydrate Pipecuronium,Dihydrate Pipecuronium Dibromide,RGH 1106,RGH1106

Related Publications

M Gazdag, and G Szepesi, and K Mihályfi, and B P Kemenesné, and P Horváth, and Z Végh, and M Rényei, and F Trischler, and S Görög
May 1992, Acta pharmaceutica Hungarica,
M Gazdag, and G Szepesi, and K Mihályfi, and B P Kemenesné, and P Horváth, and Z Végh, and M Rényei, and F Trischler, and S Görög
May 1992, Acta pharmaceutica Hungarica,
M Gazdag, and G Szepesi, and K Mihályfi, and B P Kemenesné, and P Horváth, and Z Végh, and M Rényei, and F Trischler, and S Görög
May 1992, Acta pharmaceutica Hungarica,
M Gazdag, and G Szepesi, and K Mihályfi, and B P Kemenesné, and P Horváth, and Z Végh, and M Rényei, and F Trischler, and S Görög
May 1992, Acta pharmaceutica Hungarica,
M Gazdag, and G Szepesi, and K Mihályfi, and B P Kemenesné, and P Horváth, and Z Végh, and M Rényei, and F Trischler, and S Görög
June 1992, Anesthesia and analgesia,
M Gazdag, and G Szepesi, and K Mihályfi, and B P Kemenesné, and P Horváth, and Z Végh, and M Rényei, and F Trischler, and S Görög
March 1990, Cahiers d'anesthesiologie,
M Gazdag, and G Szepesi, and K Mihályfi, and B P Kemenesné, and P Horváth, and Z Végh, and M Rényei, and F Trischler, and S Görög
May 1991, British journal of hospital medicine,
M Gazdag, and G Szepesi, and K Mihályfi, and B P Kemenesné, and P Horváth, and Z Végh, and M Rényei, and F Trischler, and S Görög
June 1989, Anesthesia and analgesia,
M Gazdag, and G Szepesi, and K Mihályfi, and B P Kemenesné, and P Horváth, and Z Végh, and M Rényei, and F Trischler, and S Görög
March 1991, European journal of anaesthesiology,
M Gazdag, and G Szepesi, and K Mihályfi, and B P Kemenesné, and P Horváth, and Z Végh, and M Rényei, and F Trischler, and S Görög
December 1989, British journal of anaesthesia,
Copied contents to your clipboard!